Auckland District Health Board promotes and adheres to the principles of ICH-GCP (Good Clinical Research Practice)
guidelines. As an international clinical research site, ADHB’s human subject protection programme is accredited to receive US federal research funding. These combined capabilities attract expert clinical staff and promote an academic approach based on the highest ethical standards and focused on applications that improve health outcomes.
Research activities at ADHB employ a range of methods to answer questions about health and healthcare delivery. These include epidemiological studies, clinical trials, outcomes research and operational studies. Many research projects at ADHB involve collaboration with university researchers both within New Zealand and around the world. Many investigators are world leaders in their field, performing studies that have contributed to the
development of cancer drugs and emerging genetic treatments, the advancement of neuroscience, surgery, paediatrics, molecular medicine, epidemiology of stroke and cardiovascular disease and the understanding of hearing disorders, diabetes and preterm labour. ADHB also hosts and supports student research at both the tertiary and specialist post doctoral level from across all disciplines.
ADHB’s Research Office facilitates a close working relationship between researchers, clinical staff, ethics
committees, funding bodies and commercial sponsors. The Research Office maintains a research database (REACH), with over 900 current projects with a total registry of 6,000. It acts as the entry point for the
approval of all research at ADHB. The Research Office’s website, www.adhb.govt.nz/ResearchOffice, provides a national resource and acts as a small clearing-house for information about funding, sponsors, resources, courses and contacts.